Abbisko Presents Phase 2 Pimicotinib Data in Chronic GVHD at ASH
08 Dec 2024 //
PR NEWSWIRE
Merck KGaA plans China submission after win for tumor drug
12 Nov 2024 //
ENDPTS
Merck, AstraZeneca Announce Phase 3 Win for Cancer Drug
12 Nov 2024 //
FIERCE BIOTECH
Pimicotinib Shows Improved Outcomes in Ph 3 Trial for Tenosynovial Tumor
11 Nov 2024 //
PR NEWSWIRE
Abbisko announces that EMA has granted orphan drug designation forPimicotinib
08 Jan 2024 //
PR NEWSWIRE
Abbisko Announces that FDA Has Granted Fast Track Designation for Pimicotinib
13 Dec 2023 //
PR NEWSWIRE
Merck KGaA, Darmstadt, Germany Strengthens Oncology Portfolio
04 Dec 2023 //
BUSINESSWIRE